RFK Jr. pledges to divest interests in CRISPR Tx, Dragonfly if HHS role confirmed

Robert F. Kennedy Jr. will be pulling his investments from two biotechs if he is confirmed to lead the U.S. Department of Health and Human Services (HHS).

As health secretary, RFK Jr. said he would divest interests in several companies—including CRISPR Therapeutics and Dragonfly Therapeutics—within 90 days, according to a Jan. 21 disclosure letter filed with the U.S. Office of Government Ethics. Other companies on the list include Amazon and Apple.